THE VASOPRESSIN SYSTEM IN DIABETES MELLITUS, OBESITY AND THE METABOLIC SYNDROME
Explore this paper's citation graph
Summary
Elevated copeptin independently predicts DM and abdominal obesity but not the cluster of MetS, which could have implications for risk assessment and novel preventive treatments and genetic variance in AVPR1B was associated with BMI.
- Type
- dissertation
- Published
- 2012-01-01
- Cited by
- 3
- References
- 114
- Access
- Open access
- OpenAlex
- https://openalex.org/W1690919075
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:70507374
Keywords
Copeptin, Medicine, Internal medicine, Endocrinology, Quartile
References
- Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas
- Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats.
- Insulin hypersensitivity in mice lacking the V1b vasopressin receptor
- Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions.
- Leisure time physical activity and metabolic syndrome in Asian Indian immigrants residing in northern California.
- Effects of vasopressin and corticosterone on fatty acid metabolism and on the activities of glycerol phosphate acyltransferase and phosphatidate phosphohydrolase in rat hepatocytes.
- Clinical risk factors, DNA variants, and the development of type 2 diabetes.
- Effects of the diabetes linked TCF7L2 polymorphism in a representative older population
- Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.
- Classifying diabetes according to the new WHO clinical stages
- Comment on the provisional report from the WHO consultation
- Plasma copeptin and the risk of diabetes mellitus
- Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice.
- Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis
- Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin.
- Management of inherited von Willebrand disease in 2007
- The Malmo Diet and Cancer Study. Design and feasibility.
- Single nucleotide polymorphism detection: allelic discrimination using TaqMan.
- C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
- Heritability of body weight: moving beyond genetics.
Cited by
Related papers
- Cystatin C and Risk of Diabetes and the Metabolic Syndrome – Biomarker and Genotype Association Analyses
- High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study
- Serum apolipoprotein B is associated with increased risk of metabolic syndrome among middle‐aged and elderly Chinese: A cross‐sectional and prospective cohort study
- Evaluation of risk for metabolic syndrome according to the fasting insulin concentration in Korean men.
- Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
- Adolescent metabolic syndrome and its components associations with incidence of type 2 diabetes in early adulthood: Tehran lipid and glucose study
- Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.
- Levels of N‐terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case‐cohort analysis of the population‐based Casale Monferrato study
- Associations Between the Metabolic Score for Insulin Resistance Index and the Risk of Type 2 Diabetes Mellitus Among Non-Obese Adults: Insights from a Population-Based Cohort Study